An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.
This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.
In this Product Explainer, Sexual Health Physician Dr Terri Foran explains estradiol and progesterone combined hormone therapy, the first and only body-identical combined treatment for post-menopausal women (6 mins).
No longer is it okay to just monitor a patient with mild hyperparathyroidism as research shows the untreated condition is associated with a significantly increased risk of cardiovascular death
Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D
Tuesday 17th March, 7pm - 9pm AEDT
Speakers
Dr Charlotte Hespe & Dr Ramy Bishay
General Practitioner & Endocrinologist
Join Dr Charlotte Hespe and Dr Ramy Bishay for this expert panel webcast presentation, where they will discuss the role of GLP-1 in the management of CKD in T2D.